Differential Immune Response to Hydroxyapatite Precursors Under Inflammatory Pressure: In Vitro and In Vivo Studies
Cells · 2026
DOI: 10.3390/cells15020101 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Irina S Fadeeva und 13 weiteren Autor:innen. Beteiligte Einrichtung: Baikov Institute of Metallurgy and Materials Science, Russian Academy of Sciences, Leninskiy Prospect 49, Moscow 119334, Russia. Hauptthemen laut MEDLINE: Inflammation, Durapatite, Immunity. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
The clinical success of calcium phosphate bone grafts (CPs) largely depends on the body’s immune response. However, traditional biocompatibility tests use healthy organisms and cannot predict effectiveness in patients with common chronic inflammatory diseases. This study examines how inflammation modulates the immune response, in vitro and in vivo, to low-temperature biomimetic CPs: dicalcium phosphate dihydrate (DCPD), octacalcium phosphate (OCP), and hydroxyapatite (HAp). In vitro studies involved human monocytes, macrophages, lymphocytes, and mesenchymal stromal cells (MSCs), with or without pro-inflammatory activation. In vivo biocompatibility was assessed via subcutaneous implantation in rats, with or without Complete Freund’s Adjuvant (CFA)-induced inflammation. Under normal conditions, all CP caused minimal immune reactivity. Inflammation-activated macrophages, however, triggered an acute reaction with significantly increased TNF-α and IL-1β secretion. Healthy and inflamed animals showed sharp contrasts. Although all materials exhibited thickened fibrous capsules during inflammation, biocompatibility varied markedly: DCPD performed best by promoting angiogenesis with minimal inflammation; HAp provoked the most severes response, including tissue necrosis and signs of rejection; OCP showed intermediate effects, with angiogenesis but notable fibrosis. Inflammatory processes critically influence CP biocompatibility; materials biocompatible in healthy organisms can induce fibrosis or rejection under inflammation. Disease-relevant, immune-challenged models are essential to predict clinical efficacy and safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Baikov Institute of Metallurgy and Materials Science, Russian Academy of Sciences, Leninskiy Prospect 49, Moscow 119334, Russia.
- Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Institutskaya Str. 3, Pushchino 142290, Russia.
- Branch of Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Prospect Nauki 6, Pushchino 142290, Russia.
ORCID-Profile: Irina S Fadeeva, Igor V Smirnov, Mikhail A Shlykov, Margarita I Kobyakova, Polina V Smirnova, Anatoliy S Senotov, Viktor A Palikov, Arina V Kholina, Vladimir S Komlev
Förderung
- Russian Science Foundation
Zitieren
APA
Fadeeva, I. S., Teterina, A. Y., Smirnov, I. V., Minaychev, V. V., Shlykov, M. A., Kobyakova, M. I., Smirnova, P. V., Senotov, A. S., Zvyagina, A. I., Palikov, V. A., Kholina, A. V., Mikhaylov, E. S., Fadeev, R. S., & Komlev, V. S. (2026). Differential Immune Response to Hydroxyapatite Precursors Under Inflammatory Pressure: In Vitro and In Vivo Studies. Cells. https://doi.org/10.3390/cells15020101
Vancouver
Fadeeva IS, Teterina AY, Smirnov IV, Minaychev VV, Shlykov MA, Kobyakova MI, et al. Differential Immune Response to Hydroxyapatite Precursors Under Inflammatory Pressure: In Vitro and In Vivo Studies. Cells. 2026. doi:10.3390/cells15020101
BibTeX
@article{Fadeeva2026,
author = {Fadeeva, Irina S and Teterina, Anastasia Yu and Smirnov, Igor V and Minaychev, Vladislav V and Shlykov, Mikhail A and Kobyakova, Margarita I and Smirnova, Polina V and Senotov, Anatoliy S and Zvyagina, Alena I and Palikov, Viktor A and Kholina, Arina V and Mikhaylov, Eugeny S and Fadeev, Roman S and Komlev, Vladimir S},
title = {Differential Immune Response to Hydroxyapatite Precursors Under Inflammatory Pressure: In Vitro and In Vivo Studies},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15020101}
}
EUVIMED